Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300690852> ?p ?o ?g. }
- W4300690852 endingPage "1149" @default.
- W4300690852 startingPage "1149" @default.
- W4300690852 abstract "Importance Antidepressant use during pregnancy has been associated with neurodevelopmental disorders in children in some studies. However, results may be explained by uncontrolled confounding by parental mental health status, genetics, and environmental factors. Objective To evaluate the association between antidepressant use in pregnancy and neurodevelopmental outcomes in children. Design, Setting, and Participants This cohort study of health care utilization data was separated into cohorts of publicly and privately insured pregnant individuals and their children nested in the Medicaid Analytic eXtract (MAX; 2000-2014) and the IBM MarketScan Research Database (MarketScan; 2003-2015). A total of 1.93 million pregnancies in MAX and 1.25 million pregnancies in MarketScan were recorded. Children were followed from birth until outcome diagnosis, disenrollment, death, or end of study (maximum 14 years). Analyses were conducted between August 2020 and July 2021. Exposures Dispensing of antidepressant medication from gestational week 19 until delivery, the period of synaptogenesis. Main Outcomes and Measures Neurodevelopmental disorders in children defined using validated algorithms. Early pregnancy exposure was considered in sensitivity analyses, and approaches to confounding adjustment included propensity score fine stratification, discontinuers comparison, and sibling analyses. Results Among the individuals included in the analysis, there were 145 702 antidepressant-exposed and 3 032 745 unexposed pregnancies; the mean (SD) age among the antidepressant exposed and unexposed was 26.2 (5.7) and 24.3 (5.8) years in MAX and 32.7 (4.6) and 31.9 (4.6) years in MarketScan, respectively; and in MAX, which collected information on race and ethnicity, 72.4% of the antidepressant-exposed and 37.1% of the unexposed individuals were White. Crude results suggested up to a doubling in risk of neurodevelopmental outcomes associated with antidepressant exposure; however, no association was observed in the most fully adjusted analyses. When comparing antidepressant-exposed and unexposed siblings, hazard ratios were 0.97 (95% CI, 0.88-1.06) for any neurodevelopmental disorder, 0.86 (95% CI, 0.60-1.23) for autism spectrum disorder, 0.94 (95% CI, 0.81-1.08) for attention-deficit/hyperactivity disorder, 0.77 (95% CI, 0.42-1.39) for specific learning disorders, 1.01 (95% CI, 0.88-1.16) for developmental speech/language disorder, 0.79 (95% CI, 0.54-1.17) for developmental coordination disorder, 1.00 (95% CI, 0.45-2.22) for intellectual disability, and 0.95 (95% CI, 0.80-1.12) for behavioral disorders. Results were generally consistent for antidepressant classes and drugs and across exposure windows. Conclusions and Relevance The results of this cohort study suggest that antidepressant use in pregnancy itself does not increase the risk of neurodevelopmental disorders in children. However, given strong crude associations, antidepressant exposure in pregnancy may be an important marker for the need of early screening and intervention." @default.
- W4300690852 created "2022-10-04" @default.
- W4300690852 creator A5004649098 @default.
- W4300690852 creator A5005129143 @default.
- W4300690852 creator A5006217491 @default.
- W4300690852 creator A5019527352 @default.
- W4300690852 creator A5019555383 @default.
- W4300690852 creator A5024775911 @default.
- W4300690852 creator A5034554999 @default.
- W4300690852 creator A5045099830 @default.
- W4300690852 creator A5053145542 @default.
- W4300690852 creator A5059368441 @default.
- W4300690852 creator A5068947552 @default.
- W4300690852 creator A5075944192 @default.
- W4300690852 date "2022-11-01" @default.
- W4300690852 modified "2023-10-11" @default.
- W4300690852 title "Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children" @default.
- W4300690852 cites W1967261707 @default.
- W4300690852 cites W1967862917 @default.
- W4300690852 cites W1982984257 @default.
- W4300690852 cites W2005569714 @default.
- W4300690852 cites W2032234096 @default.
- W4300690852 cites W2042764317 @default.
- W4300690852 cites W2055099023 @default.
- W4300690852 cites W2059674885 @default.
- W4300690852 cites W2061360351 @default.
- W4300690852 cites W2063638540 @default.
- W4300690852 cites W2071055980 @default.
- W4300690852 cites W2072718563 @default.
- W4300690852 cites W2104144931 @default.
- W4300690852 cites W2111674205 @default.
- W4300690852 cites W2114602840 @default.
- W4300690852 cites W2127147289 @default.
- W4300690852 cites W2154912010 @default.
- W4300690852 cites W2217811624 @default.
- W4300690852 cites W2218916836 @default.
- W4300690852 cites W2223680920 @default.
- W4300690852 cites W2290447957 @default.
- W4300690852 cites W2293040502 @default.
- W4300690852 cites W2515449383 @default.
- W4300690852 cites W2558201159 @default.
- W4300690852 cites W2559506670 @default.
- W4300690852 cites W2603581789 @default.
- W4300690852 cites W2606120593 @default.
- W4300690852 cites W2606395855 @default.
- W4300690852 cites W2615510373 @default.
- W4300690852 cites W2618699239 @default.
- W4300690852 cites W2652013104 @default.
- W4300690852 cites W2751458036 @default.
- W4300690852 cites W2780387110 @default.
- W4300690852 cites W2783908905 @default.
- W4300690852 cites W2992678926 @default.
- W4300690852 cites W3017480881 @default.
- W4300690852 cites W3080741489 @default.
- W4300690852 cites W3081154758 @default.
- W4300690852 cites W3126241338 @default.
- W4300690852 cites W3163458099 @default.
- W4300690852 cites W4205724682 @default.
- W4300690852 cites W4236400176 @default.
- W4300690852 cites W4252274606 @default.
- W4300690852 cites W4254030657 @default.
- W4300690852 cites W4254349977 @default.
- W4300690852 cites W4254637496 @default.
- W4300690852 doi "https://doi.org/10.1001/jamainternmed.2022.4268" @default.
- W4300690852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36190722" @default.
- W4300690852 hasPublicationYear "2022" @default.
- W4300690852 type Work @default.
- W4300690852 citedByCount "10" @default.
- W4300690852 countsByYear W43006908522022 @default.
- W4300690852 countsByYear W43006908522023 @default.
- W4300690852 crossrefType "journal-article" @default.
- W4300690852 hasAuthorship W4300690852A5004649098 @default.
- W4300690852 hasAuthorship W4300690852A5005129143 @default.
- W4300690852 hasAuthorship W4300690852A5006217491 @default.
- W4300690852 hasAuthorship W4300690852A5019527352 @default.
- W4300690852 hasAuthorship W4300690852A5019555383 @default.
- W4300690852 hasAuthorship W4300690852A5024775911 @default.
- W4300690852 hasAuthorship W4300690852A5034554999 @default.
- W4300690852 hasAuthorship W4300690852A5045099830 @default.
- W4300690852 hasAuthorship W4300690852A5053145542 @default.
- W4300690852 hasAuthorship W4300690852A5059368441 @default.
- W4300690852 hasAuthorship W4300690852A5068947552 @default.
- W4300690852 hasAuthorship W4300690852A5075944192 @default.
- W4300690852 hasConcept C118552586 @default.
- W4300690852 hasConcept C126322002 @default.
- W4300690852 hasConcept C187212893 @default.
- W4300690852 hasConcept C201903717 @default.
- W4300690852 hasConcept C2779177272 @default.
- W4300690852 hasConcept C2779234561 @default.
- W4300690852 hasConcept C54355233 @default.
- W4300690852 hasConcept C558461103 @default.
- W4300690852 hasConcept C71924100 @default.
- W4300690852 hasConcept C77350462 @default.
- W4300690852 hasConcept C86803240 @default.
- W4300690852 hasConceptScore W4300690852C118552586 @default.
- W4300690852 hasConceptScore W4300690852C126322002 @default.
- W4300690852 hasConceptScore W4300690852C187212893 @default.
- W4300690852 hasConceptScore W4300690852C201903717 @default.